Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001179110-14-014415)

Filing Details

Accession Number:
0001179110-14-014415
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-09-23 16:05:13
Reporting Period:
2014-09-23
Filing Date:
2014-09-23
Accepted Time:
2014-09-23 16:05:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1260990 Gtx Inc GTXI Pharmaceutical Preparations (2834) 621715807
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1276243 Steven Marc Hanover 175 Toyota Plaza
7Th Floor
Memphis TN 38103		 Interim Ceo, President And Coo Yes Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-09-23 5,000 $0.75 213,138 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 352,875 Indirect By Limited Liability Company
Common Stock 62,007 Indirect By Trust
Common Stock 62,007 Indirect By Trust
Footnotes
  1. An Aggregate of 5,000 shares of common stock were purchased in multiple trades on September 23, 2014 at prices ranging from $0.7499 to $0.75. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, GTx, Inc. or a shareholder of GTx, Inc. full information regarding the number of shares and prices at which the transaction was effected.